NewAmsterdam Pharma and Menarini receive positive CHMP opinion for Ubeslo and Evlarco
CHMP backs Ubeslo and Evlarco, moving obicetrapib closer to European authorization while PREVAIL tests cardiovascular outcomes.
Pharma & Biotech
Medical Devices & Diagnostics
OpenEvidence expands beyond search as Tandem partnership pushes medical AI into prescription access workflows
OpenEvidence and Tandem are linking clinical AI with prior authorization automation. Read what this could change for prescribing, access, and workflow.